Clinical Breast Cancer · 2008 · 14 citations · 35 references
MedicineOncologyPharmacologyBreast OncologyCancer PharmacologyChemotherapyBreast Cancer PharmacotherapyChemotherapy Drug AdministrationCombination ChemotherapyDose Adjustment In OncologyHigh-dose ChemotherapyMetastatic Breast CancerAnthracycline-based ChemotherapyBreast Cancer ChemotherapyCyclophosphamide DosingCyclophosphamide-based TherapyMetastatic Breast Cancer TreatmentOncology Chemotherapy DosingPharmacokinetics Of Cytotoxic Chemotherapy
35
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Martine Piccart, Marion Procter, Brian Leyland‐Jones et al. · New England Journal of Medicine · 2005 · 5.1K citations · Full text
Medicine, Oncology, Pharmacology +16
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text
Medicine, Oncology, Pharmacology +13
Marc L. Citron, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2003 · 1.6K citations
Medicine, Oncology, Pharmacology +15